Clinical trials for advancing innovative interventions for neurodegenerative diseases
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Stage 1 must establish the scientific rationale, clinical promise and expected impact in a blind outline. Stage 2 should provide adequately powered, representative clinical trials, insight into mechanisms of action, and a robust pathway for long-term efficacy, implementation and uptake. Proposals may use imaging, biomarkers, omics, registries, biobanks, AI or wearable technologies, while applying …
This two-stage Research and Innovation Action supports rigorous early-stage clinical trials of innovative interventions for non-rare neurodegenerative diseases. Projects should combine an active substance with a complementary multidisciplinary approach, such as rehabilitation, cognitive training or lifestyle change, to improve quality of life and reduce disease burden.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up